Article
Circulating Cell-Free DNA—Diagnostic and Prognostic Applications in Personalized Cancer Therapy
18 Oct 2018
Abstract excerpt
Genomic analyses in oncologic care allow for the development of more precise clinical laboratory tests that will be critical for personalized pharmacotherapy. Traditional biopsy-based approaches are limited by the availability of sequential tissue specimens to detect resistance. Blood-based genomic profiling ("liquid biopsy") is useful for longitudinal monitoring of tumor genomes and can complement biopsies....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
